Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy
Head and neck squamous cell carcinoma (HNSCC) is a very aggressive disease with a poor
prognosis for advanced-stage tumors. Recent clinical, genomic, and cellular studies have …
prognosis for advanced-stage tumors. Recent clinical, genomic, and cellular studies have …
Charged particles in radiation oncology
M Durante, JS Loeffler - Nature reviews Clinical oncology, 2010 - nature.com
Radiotherapy is one of the most common and effective therapies for cancer. Generally,
patients are treated with X-rays produced by electron accelerators. Many years ago …
patients are treated with X-rays produced by electron accelerators. Many years ago …
Proton radiobiology
F Tommasino, M Durante - Cancers, 2015 - mdpi.com
In addition to the physical advantages (Bragg peak), the use of charged particles in cancer
therapy can be associated with distinct biological effects compared to X-rays. While heavy …
therapy can be associated with distinct biological effects compared to X-rays. While heavy …
Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT‐like phenotype change and MMP‐9‐mediated degradation …
JH Zuo, W Zhu, MY Li, XH Li, H Yi… - Journal of cellular …, 2011 - Wiley Online Library
EGFR is a potent stimulator of invasion and metastasis in head and neck squamous cell
carcinomas (HNSCC). However, the mechanism by which EGFR may stimulate tumor cell …
carcinomas (HNSCC). However, the mechanism by which EGFR may stimulate tumor cell …
Head and neck cancer: from anatomy to biology
The 20th century saw great advances in anatomy‐based (surgery and radiotherapy) and
chemotherapy approaches for treating head and neck squamous cell carcinoma (HNSCC) …
chemotherapy approaches for treating head and neck squamous cell carcinoma (HNSCC) …
[HTML][HTML] Squamous cell carcinoma–similarities and differences among anatomical sites
W Yan, II Wistuba, MR Emmert-Buck… - American journal of …, 2011 - ncbi.nlm.nih.gov
Squamous cell carcinoma (SCC) is an epithelial malignancy involving many anatomical
sites and is the most common cancer capable of metastatic spread. Development of early …
sites and is the most common cancer capable of metastatic spread. Development of early …
Statins block mammalian target of rapamycin pathway: A possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases
NA Lashgari, NM Roudsari, SST Zadeh, S Momtaz… - …, 2023 - Springer
Inflammation plays a critical role in several diseases such as cancer, gastric, heart and
nervous system diseases. Data suggest that the activation of mammalian target of rapamycin …
nervous system diseases. Data suggest that the activation of mammalian target of rapamycin …
[HTML][HTML] Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy
Z Liu, M Xiao, Y Mo, H Wang, Y Han… - … journal of biological …, 2022 - ncbi.nlm.nih.gov
Protein palmitoylation is an increasingly investigated form of post-translational lipid
modification that affects protein localization, accumulation, secretion and function. Recently …
modification that affects protein localization, accumulation, secretion and function. Recently …
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and …
F Bruzzese, A Leone, M Rocco… - Journal of cellular …, 2011 - Wiley Online Library
Potentiation of epidermal growth factor receptor (EGFR) inhibitors is required in squamous
cell carcinoma of head and neck (SCCHN) to improve their therapeutic index. We …
cell carcinoma of head and neck (SCCHN) to improve their therapeutic index. We …
In vivo autofluorescence imaging of tumor heterogeneity in response to treatment
Subpopulations of cells that escape anti-cancer treatment can cause relapse in cancer
patients. Therefore, measurements of cellular-level tumor heterogeneity could enable …
patients. Therefore, measurements of cellular-level tumor heterogeneity could enable …